Business ❯ Funding ❯ Investment

Series C Funding

Startup Development Valuation Growth Esusu Valuation Valuation Nothing TWG Global Healthcare Startups Strategic Asset Purchase

Biofrontera Reports Record 2025 Revenue of $41.7 Million and Best-Ever Q4 at $17.1 Million

Management attributed the outperformance to broader adoption of its Ameluz photodynamic therapy.

Nothing to Open First India Flagship in Bengaluru on February 14

Esusu Raises $50 Million at $1.2 Billion Valuation to Scale Rent Reporting

Hippocratic AI Raises $126 Million at $3.5 Billion Valuation in Series C

Nothing Raises $200 Million at $1.3 Billion Valuation to Launch AI‑Native Devices in 2026